`DISTRICT OF KANSAS
`
`
`TROY R. NORRED, M.D.,
`
`
`
`
`
`
`
`
`
`Plaintiff,
`
`
`
`
`
`
`
`v.
`
`
`
`
`
`
`
`
`
`
`MEDTRONIC, INC., et al.,
`
`
`
`
`
`
`
`
`
`Defendants.
`
`
`
`
`
`
`
`
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Case No. 13-CV-2061 EFM/DJW
`
`PLAINTIFF’S INITIAL INFRINGEMENT CONTENTIONS
`
`Pursuant to paragraph 4.a. of the Scheduling Order (Doc. 36), Plaintiff provides the
`
`following initial infringement contentions.
`
`a.
`
`Claims infringed
`
`Claims 16, 19, 20 – 24 of U.S. Patent No. 6,482,228 are infringed.
`
`b.
`
`Accused Devices
`
`The Accused Devices include the CoreValve and
`
`the CoreValve Evolut. Each of these devices infringes each of
`
`the asserted claims.
`
`
`
`c.
`
`Claim Charts
`
`The structure of the CoreValve is essentially the same as the structure of the
`
`CoreValve Evolut. Accordingly, identification of each claim element and the corresponding
`
`structural element of the Accused Devices is only done for the CoreValve.
`
`
`
`1
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 1
`
`
`
`
`
`1. Claim 16
`
`16. An aortic valve for regulating a blood flow through an aortic channel surrounded
`
`by an aortic wall upon placement therein, said valve comprising:
`
`(a) a ring member having
`
`(1) a circumference adapted to seat about an aortic wall surrounding an aortic
`
`channel, said ring including
`
`(2) an aperture for blood flow therethrough;
`
`(b) a membrane having
`
`(1) first and
`
`(2) second spaced-apart open ends, said membrane
`
`(3) made of a material resistant to a fluid flow therethrough; and
`
`(c) means for mounting said first open end of said membrane about said ring
`
`aperture with said second open end displaced therefrom, said means moving
`
`said membrane second end between
`
`(1) a first open position to allow a blood flow therethrough and
`
`(2) a second closed position to preclude a blood flow therethrough.
`
`
`
`The Accused Devices infringe Claim 16 of the ‘228 Patent because all of the
`
`limitations of Claim 16 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`2
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 2
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`
`
`
`
`16. An aortic valve for regulating a
`blood flow through an aortic channel
`surrounded by an aortic wall upon
`placement therein
`
`16(a)(2) an aperture for blood flow
`therethrough
`
`16(b) a membrane
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 3
`
`
`
`
`
`
`
`
`
`
`
`4
`
`16(b)(2) second space-apart open
`end[s]
`
`16(b)(3) made of a material resistant
`to a fluid flow therethrough
`
`16(b)(1) first [open end]
`
`16(c) means for mounting said first
`open end of said membrane about
`said ring aperture with said second
`open end displaced therefrom
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 4
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`16(c)(1) a first open position to allow
`a blood flow therethrough
`
`16(c)(2) a second closed position to
`preclude a blood flow therethrough
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 5
`
`
`
`
`
`2. Claim 19
`
`19. The aortic valve as claimed in claim 16 further comprising means for
`
`maintaining said ring member in said seat about said aortic wall.
`
`
`
`The Accused Devices infringe Claim 19 of the ‘228 Patent because each of the
`
`limitations of Claim 19 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`.
`
`6
`
`
`
`
`
`19. The aortic valve as claimed in
`claim 16 further comprising means
`for maintaining said ring member in
`said seat about the aortic wall.
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 6
`
`
`
`
`
`3. Claim 20
`
`20. An aortic valve for controlling a blood flow through an aortic channel
`
`upon placement therein, said valve comprising:
`
`(a) a tissue valve having
`
`(1) an interior member made of a tissue material and presenting
`
`(2) an opening movable between open and closed positions;
`
`(b) a ring member surrounding said tissue valve, said ring member having
`
`(1) an outer circumference adapted to seat said ring member about an
`
`aortic wall surrounding an aortic channel;
`
`(c) means for maintaining said ring member in said seated position about
`
`the aortic wall,
`
`(a)(1) said tissue valve interior member responsive to changes of
`
`conditions within the aorta for movement of said opening between
`
`(i) a first closed position and
`
`(ii) a second open position.
`
`The Accused Devices infringe claim 20 of the ‘228 Patent because each of the
`
`limitations of claim 20 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`7
`
`20. An aortic valve for controlling a
`blood flow through an aortic channel
`upon placement therein
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 7
`
`
`
`
`
`
`
`
`
`
`
`
`
`8
`
`20(a) a tissue valve
`
`20(a)(1) an interior member made of
`a tissue material
`
`20(a)(2) an opening movable
`between open and closed positions
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 8
`
`
`
`
`
`
`
`
`
`9
`
`20(b) a ring member surrounding
`said tissue valve, said ring member
`
`20(b)(1) an outer circumference
`adapted to seat said ring member
`about an aortic wall surrounding an
`aortic channel
`
`Side View
`
`Top View
`
`Bottom View
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 9
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`10
`
`20(a)(1) said tissue valve interior
`member responsive to changes of
`conditions within the aorta for
`movement of said opening between
`(i) a first closed position
`
`20(a)(1) said tissue valve interior
`member responsive to changes of
`conditions within the aorta for
`movement of said opening between
`(ii) a second open position
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 10
`
`
`
`
`
`4. Claim 21
`
`21. The aortic valve as claimed in claim 20 wherein said tissue valve interior
`
`member is responsive to changes in blood pressure in the aorta whereby to
`
`move said tissue valve between said first and second positions.
`
`
`
`The Accused Devices infringe Claim 21 of the ‘228 Patent because each of the
`
`limitations of Claim 21 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`11
`
`21. The aortic valve as claimed in
`claim 20 wherein said tissue valve
`interior member is responsive to
`changes in blood pressure in the
`aorta whereby to move said tissue
`valve between said first and second
`positions.
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 11
`
`
`
`
`
`5. Claim 22
`
`22. The aortic valve as claimed in claim 21 wherein said tissue valve interior
`
`member moves to said second position in response to systolic ejection of
`
`blood from the left ventricle in which the blood pressure in the left ventricle is
`
`greater than the blood pressure in the aortic channel..
`
`
`
`The Accused Devices infringe Claim 22 of the ‘228 Patent because each of the
`
`limitations of Claim 22 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`12
`
`Valve Open
`
`22. The aortic valve as claimed in
`claim 21 wherein said tissue valve
`interior member moves to said
`second position in response to
`systolic ejection of blood from the
`left ventricle in which the blood
`pressure in the left ventricle is
`greater than the blood pressure in
`the aortic channel.
`
`Blood Pressure/Flow
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 12
`
`
`
`
`
`6. Claim 23
`
`23. The aortic valve as claimed in claim 21 wherein said tissue valve interior
`
`member moves to said first position in response to diastolic filling of the left
`
`ventricle in which the blood pressure in the aortic channel is greater than the
`
`blood pressure in the left ventricle.
`
`
`
`The Accused Devices infringe Claim 23 of the ‘228 Patent because each of the
`
`limitations of Claim 23 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`
`
`13
`
`Blood Pressure/Flow
`
`23. The aortic valve as claimed in
`claim 21 wherein said tissue valve
`interior member moves to said first
`position in response to diastolic
`filling of the left ventricle whereby
`the blood pressure in the aortic
`channel is greater than the blood
`pressure in the left ventricle
`
`Valve Closed
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 13
`
`
`
`
`
`7. Claim 24
`
`24. The aortic valve as claimed in claim 20 wherein ring member contacts the
`
`wall of the aortic channel and seals said ring against the aortic channel wall to
`
`reduce blood flow therearound.
`
`The Accused Devices infringe Claim 24 of the ‘228 Patent because each of the
`
`limitations of Claim 24 are literally found in the Accused Devices. Below are pictures and
`
`illustrations of the CoreValve with each of the limitations identified.
`
`
`
`
`
`
`
`
`
`
`
`14
`
`24. The aortic valve as claimed in
`claim 20 wherein said ring member
`contacts the wall of the aortic
`channel and seals said ring against
`the aortic channel wall to reduce
`blood flow therearound.
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 14
`
`
`
`
`
`d.
`
`Infringement
`
`Claims 16, 19, 20 – 24 of U.S. Patent No. 6,482,228 are literally infringed by the
`
`Accused Devices.
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BARTLE & MARCUS, LLC
`/s/ David L. Marcus
`
`
`David L. Marcus, KS Bar No. 18034
`
`1100 Main Street, Suite 2730
`
`Kansas City, Missouri 64105
`
`Telephone: 816- 256-4699
`
`Facsimile: 816- 222-0534
`
` dmarcus@bmlawkc.com
`
`-and-
`
`ERICKSON, KERNELL, DERUSSEAU
`& KLEYPAS, LLC
`
`
`
`/s/ James J. Kernell
`James J. Kernell, KS Bar No. 19559
`ERICKSON, KERNELL, DERUSSEAU
`& KLEYPAS, LLC
`8900 State Line Road, Suite 500
`Leawood, Kansas 66206
`Telephone: 913-549-4700
`Facsimile: 913-549-4646
`jjk@kcpatentlaw.com
`
`Attorneys for Plaintiff Troy R. Norred
`
`
`
`
`
`
`
`15
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Medtronic, Medtronic Vascular,
`and Medtronic CoreValve
`Exhibit 1020-1 - Page 15